Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Hippocampal volume change in the Alzheimer Disease Cholesterol-Lowering Treatment trial.

Sparks DL, Lemieux SK, Haut MW, Baxter LC, Johnson SC, Sparks LM, Sampath H, Lopez JE, Sabbagh MH, Connor DJ.

Cleve Clin J Med. 2008 Mar;75 Suppl 2:S87-93.

PMID:
18540154
2.

Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C.

Curr Alzheimer Res. 2005 Jul;2(3):343-53.

PMID:
15974900
3.

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C.

Arch Neurol. 2005 May;62(5):753-7.

PMID:
15883262
4.

Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).

Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolkowski C, Lochhead J, Browne P.

Curr Alzheimer Res. 2005 Dec;2(5):527-39.

PMID:
16375656
5.

Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.

Sever PS, Poulter NR, Dahlof B, Wedel H; ASCOT Investigators.

J Hypertens. 2009 May;27(5):947-54. doi: 10.1097/HJH.0b013e328326cb1a.

PMID:
19318984
6.

Statin therapy for Alzheimer's disease: will it work?

Petanceska SS, DeRosa S, Olm V, Diaz N, Sharma A, Thomas-Bryant T, Duff K, Pappolla M, Refolo LM.

J Mol Neurosci. 2002 Aug-Oct;19(1-2):155-61.

PMID:
12212773
7.
8.

[A new approach to the treatment of dyslipidemia].

Kevelaitiene S, Slapikas R.

Medicina (Kaunas). 2008;44(5):407-13. Review. Lithuanian.

9.

Statin therapy works for patients who have type 2 diabetes.

Korber KE.

JAAPA. 2008 Oct;21(10):58, 60. No abstract available.

PMID:
19024640
10.

[Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].

Liguori E, Sarcinella R.

Minerva Cardioangiol. 1998 Sep;46(9):317-8. Italian. No abstract available.

PMID:
10021861
12.

A position paper: based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer's Disease Cholesterol-Lowering Treatment Trial (ADCLT).

Sparks DL, Lopez J, Connor D, Sabbagh M, Seward J, Browne P; Alzheimer's Disease Cholesterol-Lowering Treatment Team.

J Mol Neurosci. 2003;20(3):407-10.

PMID:
14501025
13.

Statin face-off. Surprises from the first head-to-head comparison.

Gupta S.

Time. 2003 Nov 24;162(21):83. No abstract available.

PMID:
14666603
14.

Statin therapy and the elderly: SAGE advice?

Gotto AM Jr.

Circulation. 2007 Feb 13;115(6):681-3. No abstract available.

15.
16.

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.

Bloom JM.

N Engl J Med. 1999 Dec 9;341(24):1854-5. No abstract available.

PMID:
10610466
17.

The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.

Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H; LEADe investigators.

Alzheimers Dement. 2008 Mar;4(2):145-53. doi: 10.1016/j.jalz.2008.02.001.

PMID:
18631958
18.

Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.

Oka H, Ikeda S, Koga S, Miyahara Y, Kohno S.

Heart Vessels. 2008 Jul;23(4):249-56. doi: 10.1007/s00380-008-1038-9. Epub 2008 Jul 23.

PMID:
18649055
19.

Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.

Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Kihara T, Tanaka N, Nakaya K, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):222-8. doi: 10.1097/HJR.0b013e32832948a0.

PMID:
19242355
20.

Potential neurological value of statins increases.

Bonetta L.

Nat Med. 2002 Jun;8(6):541. No abstract available.

PMID:
12042786

Supplemental Content

Support Center